BallsM., BlaauboerB., BrusickD., FrazierJ., LambD., PembertonM., ReinhardtC., RoberfroidM., RosenkrantzH., SchmidB., SpielmannH., StammatiA-L., & WalumE. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures.ATLA18, 313–317.
2.
FederP.I., LordoR.A., DiPasqualeL.C., BagleyD.M., ChudkowskiM., DemetruliasJ.L., KintzeK.L., MarenusK.D., PapeW.J.W., RoddyM., SchnetzingerR., SilberP.M., TealJ.J., WeiseS.L., and GettingsS.D. (1991). The CTFA evaluation of alternatives program: an evaluation of in vitro alternatives to the Draize primary eye irritation test. Phase I: hydroalcoholic formulation. Part 1: statistical methods.In Vitro Toxicology4, 231–246.
3.
GettingsS.D., TealJ.J., BagleyD.M., DemetruliasJ.L., DiPasqualeL.C., HintzeK.L., RozenM.G., WeiseS.L., ChudkowskiM., MarenusK.D., PapeW.J.W., RoddyM., SchnetzingerR., SilberP.M., GlazaS.M., and KurtzP.J. (1991). The CTFA evaluation of alternatives program: an evaluation of in vitro alternatives to the Draize primary eye irritation test. Phase I: hydroalcoholic formulations. Part 2: data analysis and biological significance.In Vitro Toxicology4, 247–288.
4.
KruszewskiF.H., HearnL.H., SmithK.T., TealJ.J., GordonV.C., and DickensM.S. (1992). Application of the EYTEX™ system to the evaluation of cosmetic products and their ingredients.ATLA20, 146–163.
5.
PelouxA.F., FédériciC., BichetN., GouyD., & CanoJ-P. (1992). Hepatocytes in primary culture: an alternative to LD50 testing? Validation of a predictive model by multivariate analysis.ATLA20, 8–26.
6.
FrazierJ.M. (1990). Scientific criteria for validation of in vitro toxicity tests. Environment Monographs, no. 36, 62 pp. Paris: OECD.
7.
GilmanA.G., RallT.W., NiesA.S., and TaylorP. (1990). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn.Oxford: Pergamon Press.